Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides

被引:182
作者
Mai, A
Massa, S
Pezzi, R
Simeoni, S
Rotili, D
Nebbioso, A
Scognamiglio, A
Altucci, L
Loidl, P
Brosch, G
机构
[1] Univ Roma La Sapienza, Dipartimento Studi Farmaceut, Inst Pasteur, I-00185 Rome, Italy
[2] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy
[3] Seconda Univ Studi Napoli, Dipartimento Patol Gen, I-80138 Naples, Italy
[4] AIRC, CEINGE, Ctr Oncogen, Naples, Italy
[5] Univ Innsbruck, Dept Mol Biol, A-6020 Innsbruck, Austria
关键词
D O I
10.1021/jm049002a
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chemical manipulations performed on aroyl-pyrrolyl-hydroxyamides (APHAs) led to (aryloxopropenyl)pyrrolyl hydroxamates 2a-w, and their inhibition against maize HDACs and their class I or class II HDAC selectivity were determined. In particular, from these studies some benzene meta-substituted compounds emerged as highly class II (IIa)-selective HDAC inhibitors, the most selective being the 3-chloro- and 3-fluoro-substituted compounds 2c (SI = 71.4) and 2f (SI = 176.4). The replacement of benzene with a 1-naphthyl ring afforded 2s, highly active against the class II homologue HD1-A (IC50 = 10 nM) but less class II-selective than 2c,f When tested against human HDAC1 and HDAC4, 2f showed no inhibitory activity against HDAC1 but was able to inhibit HDAC4. Moreover, in human U937 acute myeloid leukaemia cells 2f did not produce any effect on apoptosis, granulocytic differentiation, and the cell cycle, whereas 2s (that retain class I HDAC inhibitory activity) was 2-fold less potent than SAHA used as reference.
引用
收藏
页码:3344 / 3353
页数:10
相关论文
共 86 条
[41]   Biochemical methods for analysis of histone deacetylases [J].
Kolle, D ;
Brosch, G ;
Lechner, T ;
Lusser, A ;
Loidl, P .
METHODS, 1998, 15 (04) :323-331
[42]   Histone acetylases and deacetylases in cell proliferation [J].
Kouzarides, T .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1999, 9 (01) :40-48
[43]   Histone deacetylase as a therapeutic target [J].
Krämer, OH ;
Göttlicher, M ;
Heinzel, T .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2001, 12 (07) :294-300
[44]  
KRUH J, 1982, MOL CELL BIOCHEM, V42, P65
[45]   A comparative study of histone deacetylases of plant, fungal and vertebrate cells [J].
Lechner, T ;
Lusser, A ;
Brosch, G ;
Eberharter, A ;
GoralikSchramel, M ;
Loidl, P .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1996, 1296 (02) :181-188
[46]   RPD3-type histone deacetylases in maize embryos [J].
Lechner, T ;
Lusser, A ;
Pipal, A ;
Brosch, G ;
Loidl, A ;
Goralik-Schramel, M ;
Sendra, R ;
Wegener, S ;
Walton, JD ;
Loidl, P .
BIOCHEMISTRY, 2000, 39 (07) :1683-1692
[47]   Expression and functional characterization of recombinant human HDAC1 and HDAC3 [J].
Li, JL ;
Staver, MJ ;
Curtin, ML ;
Holms, JH ;
Frey, RR ;
Edalji, R ;
Smith, R ;
Michaelides, MR ;
Davidsen, SK ;
Glaser, KB .
LIFE SCIENCES, 2004, 74 (22) :2693-2705
[48]   Identification of maize histone deacetylase HD2 as an acidic nucleolar phosphoprotein [J].
Lusser, A ;
Brosch, G ;
Loidl, A ;
Haas, H ;
Loidl, P .
SCIENCE, 1997, 277 (5322) :88-91
[49]   Histone deacetylation in epigenetics: An attractive target for anticancer therapy [J].
Mai, A ;
Massa, S ;
Rotili, D ;
Cerbara, I ;
Valente, S ;
Pezzi, R ;
Simeoni, S ;
Ragno, R .
MEDICINAL RESEARCH REVIEWS, 2005, 25 (03) :261-309
[50]   3-(4-aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors.: 2.: Effect of pyrrole-C2 land/or -C4 substitutions on biological activity [J].
Mai, A ;
Massa, S ;
Cerbara, I ;
Valente, S ;
Ragno, R ;
Bottoni, P ;
Scatena, R ;
Loidl, P ;
Brosch, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) :1098-1109